Tag: Radiation
Decision Regret Uncommon After Radical Prostatectomy, IMRT
Overall decision regret for 16.9 percent of patients; more regret for RP than radiotherapy component
Vaginal Brachytherapy Cuts Mortality in Early Uterine Cancer
Reduction in mortality for stage IA and IB disease; radiotherapy underused in this population
Less Cognitive Deterioration With Stereotactic Radiosurgery Alone
Results seen in patients with one to three brain metastases
Radiotherapy Use for DCIS Tied to Subsequent Mastectomy Risk
Women with DCIS in area with high RT use have higher odds of mastectomy at time of second event
No Excess Mortality Seen for More Recently Graduated Radiologists
Efforts to improve monitoring and protective equipment have paid off, researchers say
Possible Benefit for Addition of Cetuximab to RT in Laryngeal CA
Nonsignificant increase in laryngeal preservation, laryngectomy-free survival with cetuximab plus RT
Docs Tending Away From Post-Prostatectomy Adjuvant RT
Urologists in Australia less favorable toward adjuvant radiotherapy in 2015 versus 2012
ADT Plus Radiotherapy Ups Survival in Metastatic Prostate CA
Superior median, five-year OS for prostate RT plus ADT versus ADT alone in propensity score analyses
SBRT, Proton Beam Therapy Use Increasing for Prostate CA
Median cost of stereotactic body radiotherapy lower than IMRT or proton beam therapy
Additional Treatments Offer Little Benefit for Pancreatic Cancer
Neither extra chemotherapy drug nor add-on radiation aided longevity in French trial
